Talis Biomedical Corporation (NASDAQ: TLIS)
$4.4100
+2.5500 ( +5.28% ) 51.0K
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
Market Data
Open
$4.4100
Previous close
$1.8600
Volume
51.0K
Market cap
N/A
Day range
$3.8850 - $4.4750
52 week range
$1.3700 - $9.6000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 1 | Aug 14, 2024 |
| nt | Quarterly Reports | 1 | Aug 14, 2024 |
| 3 | Insider transactions | 1 | Aug 07, 2024 |
| 3 | Insider transactions | 1 | Aug 07, 2024 |
| 8-k | 8K-related | 15 | Aug 06, 2024 |
| 8-k | 8K-related | 12 | Jun 25, 2024 |
| 8-k | 8K-related | 12 | Jun 03, 2024 |
| 10-q | Quarterly Reports | 53 | May 08, 2024 |
| 8-k | 8K-related | 12 | May 03, 2024 |
| 8-k | 8K-related | 11 | Apr 11, 2024 |